bpc-157 adverse effects case report human FDA Committee Votes to Ease Restrictions on Six Peptides bpc-157 safety human case reports

BPC-157 Capsules is sold exclusively for research use and is not approved for human consumption

The semi-rigid vial container is fabricated from a special formulation of polyolefin, a copolymer of ethylene and propylene

As with all research compounds, investigators should implement appropriate laboratory safety protocols and follow institutional guidelines for handling investigational chemical compounds in controlled research environments

A 2025 intravenous safety study involving two healthy adults found infusions up to 20 mg well tolerated, with no adverse events or clinically meaningful changes in vital signs or laboratory biomarkers